Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H27ClFN5O3 |
InChIKeyQRSMRDQGARXWNY-UHFFFAOYSA-N |
CAS Registry3034567-54-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 22 Dec 2022 |